Chia JWK, Segelov E, Deng Y, Ho GF, Wang W, Han S et al.
Lancet Gastrohepatol 2025; 10: 198-209.
Some 1550 patients were randomly allocated 200mg Aspirin per day or placebo for three years, and followed for five years. Disease-free survival was 77 per cent in the aspirin group versus 74.8 per cent in controls, P=0.38.
Comment: An aspirin a day doesn’t keep recurrence away.
.png)
.jpg){kind=logo}
